News Esya Labs Supports Drug Discovery Efforts at Novartis: ‘This is Only the Beginning,’ says CEO Esya Labs, which is developing several ground-breaking novel research assays, today has announced that Novartis is among the first companies to use its technology. Novartis, a global healthcare company, has...
News University of Chicago Joins Global Scholars Program The University of Chicago has joined the competitive program which is supported by the Novartis Institutes for BioMedical Research (NIBR) and designed to provide researchers with funding as well as access...
News Esya Labs Leads Paradigm Shift in Alzheimer’s Using Novel Biomarkers and AI for Revolutionary 360° Perspective of Disease Esya Labs is developing tools for the early, precise, and cost-effective detection of neurodegenerative diseases to support drug discovery and personalized medicine efforts. In her lab at the University of Chicago, Chemistry...
News Reluctant Renaissance Man Even though Olaf Schneewind operates seamlessly in many overlapping scientific, academic and corporate circles, he denies being a Renaissance Man. “I’m just a complete workaholic, 365 days of the year,”...
News Esya Labs and HeioThera Receive $250,000 Investment from the George Shultz Innovation Fund The 2021 Spring Cohort of the George Shultz Innovation Fund has invested $250,000 in both Esya Labs and HeioThera – and this number will increase as they solidify additional funding....
News Cancer Detection, Oil Spill Cleanup, Quantum Computing, and a New Medical Device: Meet the Spring 2022 Innovation Fund Finalists Four teams have been selected as finalists for the George Shultz Innovation Fund spring 2022 investment cycle – bringing to the forefront solutions for scaling quantum computers, sustainably cleaning oil...
News How Five UChicago Innovators Are Fighting the IP Gender Gap It is estimated that only 16.2% of inventors named in international patent applications were women in 2022, according to data from the World Intellectual Property Organization (WIPO). In an analysis...
